These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21266979

  • 1. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
    Friend E, Yadegarfar G, Byrne C, Johnson CD, Sezer O, Pucciarelli S, Pereira SP, Chie WC, Banfield A, Ramage JK, EORTC Quality of Life Group.
    Br J Cancer; 2011 Feb 15; 104(4):587-92. PubMed ID: 21266979
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
    Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M, Buckels J, EORTC Quality of Life Group.
    Eur J Cancer; 2003 Jun 15; 39(9):1259-63. PubMed ID: 12763214
    [Abstract] [Full Text] [Related]

  • 4. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D, Bereza K, Sanna B, Kucharska E, Tomaszewska IM, Dudkiewicz Z, Skotnicki P, Bottomley A, Tomaszewski KA.
    Eur J Oncol Nurs; 2017 Aug 15; 29():148-154. PubMed ID: 28578847
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, EORTC Quality of Life Group.
    Eur J Cancer; 2004 Nov 15; 40(16):2439-44. PubMed ID: 15519517
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC, Johnson CD, Gilbert A, Tomaszewski KA, Chu W, Chung HT, Dennis K, Desideri I, Glynne-Jones R, Grønlie Guren M, Kardamakis D, Nugent K, Schmidt H, Sebag-Montefiore D, Vassiliou V, EORTC Quality of Life Group.
    Radiother Oncol; 2018 Feb 15; 126(2):222-228. PubMed ID: 29217122
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
    Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, Nicolatou-Galitis O, Pinto M, Raber-Durlacher J, Singer S, Tomaszewska IM, Tomaszewski KA, Verdonck-de Leeuw I, Yarom N, Winstanley JB, Herlofson BB, EORTC QoL Group.
    Support Care Cancer; 2016 Sep 15; 24(9):3915-24. PubMed ID: 27113466
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.
    Davies AH, Larsson G, Ardill J, Friend E, Jones L, Falconi M, Bettini R, Koller M, Sezer O, Fleissner C, Taal B, Blazeby JM, Ramage JK, EORTC Quality of Life Group.
    Eur J Cancer; 2006 Mar 15; 42(4):477-84. PubMed ID: 16412628
    [Abstract] [Full Text] [Related]

  • 16. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, Al-Kadhimi G, Heaton N, Calara J, Collins P, Caddick K, Costantini A, Vilgrain V, Trinquart L, Chiang C, EORTC Quality of Life Group.
    Hepatology; 2012 Apr 15; 55(4):1122-9. PubMed ID: 22105642
    [Abstract] [Full Text] [Related]

  • 17. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
    Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszweksi KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group.
    Ann Oncol; 2020 Feb 15; 31(2):283-288. PubMed ID: 31959345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
    Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, Farndon JR.
    Eur J Cancer; 1996 Oct 15; 32A(11):1912-7. PubMed ID: 8943674
    [Abstract] [Full Text] [Related]

  • 20. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
    Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, Rosemeyer D, Johnson CD, Alderson D, EORTC Quality of Life Group.
    Eur J Cancer; 2001 May 15; 37(8):966-71. PubMed ID: 11334720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.